MDRNA CEO Michael French has been appointed to the company’s board, and has also been named as president.
French joined MDRNA, which previously was known as Nastech Pharmaceutical (see RNAi News, 6/12/2008), in June. He previously served as senior vice president of corporate development at Sirna Therapeutics.
Victor Ambros, David Baulcombe, and Gary Ruvkun were awarded this year’s Albert Lasker Medical Research Awards for their pioneering efforts in discovering microRNAs.
Ambros recently became a professor at the University of Massachusetts Medical School. Baulcombe is a professor at the University of Cambridge, and Ruvkunis a professor at Harvard Medical School.